|
ARHGAP12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.2245999999605E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.3182000000015E-05 |
| Normal-vs-Stage2 |
2.039400E-01 |
| Normal-vs-Stage3 |
3.58039999981408E-07 |
| Normal-vs-Stage4 |
4.18700000004435E-06 |
| Stage1-vs-Stage2 |
4.135600E-01 |
| Stage1-vs-Stage3 |
4.360100E-02 |
| Stage1-vs-Stage4 |
2.265600E-01 |
| Stage2-vs-Stage3 |
8.231600E-02 |
| Stage2-vs-Stage4 |
1.729020E-01 |
| Stage3-vs-Stage4 |
4.878400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.7794000000414E-06 |
| Normal-vs-AfricanAmerican |
3.31580000001441E-06 |
| Normal-vs-Asian |
2.626200E-01 |
| Caucasian-vs-AfricanAmerican |
2.530000E-01 |
| Caucasian-vs-Asian |
3.311000E-01 |
| AfricanAmerican-vs-Asian |
2.296800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0151999999829E-06 |
| Normal-vs-Female |
5.9428000000028E-05 |
| Male-vs-Female |
6.456800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.461030E-03 |
| Normal-vs-Age(41-60Yrs) |
2.156500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.45109999996718E-06 |
| Normal-vs-Age(81-100Yrs) |
4.101800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.117400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.726400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.853200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.094000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.774400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.858400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.678200E-01 |
| Normal-vs-Grade 2 |
3.560800E-03 |
| Normal-vs-Grade 3 |
2.2215995709729E-10 |
| Normal-vs-Grade 4 |
2.94949999979366E-08 |
| Grade 1-vs-Grade 2 |
4.281000E-01 |
| Grade 1-vs-Grade 3 |
2.447900E-02 |
| Grade 1-vs-Grade 4 |
1.953750E-02 |
| Grade 2-vs-Grade 3 |
7.764700E-03 |
| Grade 2-vs-Grade 4 |
2.823600E-03 |
| Grade 3-vs-Grade 4 |
2.209200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.236600E-03 |
| Normal-vs-ccB subtype |
1.68170999998996E-05 |
| ccA subtype-vs-ccB subtype |
7.083700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.50630000000218E-05 |
| Normal-vs-N1 |
5.363600E-02 |
| N0-vs-N1 |
8.633800E-01 |
|
|
